AI assistant
Sending…
Medpace Holdings, Inc. — Director's Dealing 2024
Feb 28, 2024
30442_dirs_2024-02-28_cc26c8d8-61fe-4210-9373-c7d77972af2f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Medpace Holdings, Inc. (MEDP)
CIK: 0001668397
Period of Report: 2024-02-26
Reporting Person: Keating Ashley M. (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-02-26 | Common Stock | M | 500 | $54.99 | Acquired | 500 | Direct |
| 2024-02-26 | Common Stock | S | 246 | $403.894 | Disposed | 254 | Direct |
| 2024-02-26 | Common Stock | S | 254 | $404.68 | Disposed | 0 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-02-26 | Stock Option (Right to Buy) | $54.99 | M | 500 | Disposed | 2026-05-17 | Common Stock (500) | Direct |
Footnotes
F1: The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period.
F2: The option vested in full on May 14, 2020.
More from Medpace Holdings, Inc.
Board/Management Information
2026
Jun 4
Declaration of Voting Results & Voting Rights Announcements
2026
May 19
Interim / Quarterly Report
2026
Apr 23
Regulatory Filings
2026
Apr 22
Annual Report
2026
Apr 1
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19
Regulatory Filings
2026
Mar 17
Director's Dealing
2026
Feb 18